Aster DM Quality Care (NSE:ASTERDM) Growth Rank: 7 (As of Aug. 03, 2026) — 17% Above Median

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:ASTERDM Aster DM Quality Care Ltd NSE:ASTERDM
72 GF Score
Price ₹822.15
GF Value ₹724.56
Valuation Modestly Overvalued
! 7 Warning Signs
View Full Analysis

What is Aster DM Quality Care Growth Rank?

Aster DM Quality Care NSE:ASTERDM +1.00% 72 Growth Rank is 7 as of Aug. 03, 2026, which is 17% above its 10-year median of 6.00. GuruFocus rates NSE:ASTERDM with a GF Score™ of 72/100 and a GF Value™ of ₹724.56 (Modestly Overvalued). The stock has 7 warning signs investors should review.

Aster DM Quality Care has the Growth Rank of 7.

GuruFocus Growth Rank measures the growth of a company in terms of its revenue and profitability, rated on a scale from 1 to 10. Historically, the companies with the highest growth ranks performed the best over the long term. It is calculated using the following criteria:

1. 5-year revenue growth rate, the higher, the better.
2. 3-year revenue growth rate, the higher, the better.
3. 5-year EBITDA growth rate, the higher, the better.
4. The predictability of 5-year revenue. The most consistent it is, the higher the rank.

A higher score reflects a greater ability to drive business growth, with companies considered to have strong and sustainable expansion potential. Conversely, a lower score indicates challenges in achieving consistent growth and scalability.

GuruFocus found that the Growth Rank is the second of the two most-sensitive parameters among the five parameters checked. Please click GF Score to see more details on GF Score's 5 Key Aspects of Analysis.

Please note that we are using the five-year EBITDA growth rate as a parameter, so the company needs to have had positive growth over that time. The reason we use EBITDA instead of earnings per share is that with EBITDA, we can rank a lot more companies since a company may have positive EBITDA but negative EPS. Since we are looking at the growth here, EBITDA gives us a pretty clear picture about the growth in the company's business operations.

Aster DM Quality Care Growth Rank Related Terms

NSE:ASTERDM vs HCA, THC, DVA: Growth Rank Comparison

For the Medical Care Facilities subindustry, Aster DM Quality Care's Growth Rank, along with its competitors' market caps and Growth Rank data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Aster DM Quality Care Growth Rank vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Aster DM Quality Care's Growth Rank distribution charts can be found below:

* The bar in red indicates where Aster DM Quality Care's Growth Rank falls into.


NSE:ASTERDM
72GF Score
Aster DM Quality Care Ltd NSE:ASTERDM
Growth Rank is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Growth Rank →
What does a Growth Rank of 7 mean?
Aster DM Quality Care (NSE:ASTERDM) has a Growth Rank of 7 as of Aug. 03, 2026. Growth Rank measures the growth of a company in terms of its revenue and profitability. View historical data on Aster DM Quality Care and its competitors. This is 17% above median its historical median of 6.00. Over the past decade, Aster DM Quality Care's Growth Rank has ranged from 4.00 to 10.00.
Is Aster DM Quality Care's Growth Rank too high?
Aster DM Quality Care's current Growth Rank of 7 is 17% above median its 10-year median of 6.00. Over the past 10 years, this metric has ranged from a low of 4.00 to a high of 10.00. Overall, Aster DM Quality Care has a GF Score™ of 72/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Aster DM Quality Care's Growth Rank compare to HCA and THC?
Aster DM Quality Care's Growth Rank of 7 can be compared against companies in the Healthcare Providers & Services industry. Historically, Aster DM Quality Care's own Growth Rank has ranged from 4.00 to 10.00 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Growth Rank for a Healthcare Providers & Services company?
A good Growth Rank depends on the Healthcare Providers & Services industry context. However, Growth Rank should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Growth Rank mean?
A high Growth Rank can signal that a stock is expensive relative to its fundamentals. Growth Rank measures the growth of a company in terms of its revenue and profitability. View historical data on Aster DM Quality Care and its competitors. Aster DM Quality Care's current Growth Rank is 7, which is 17% above median its own 10-year median of 6.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Aster DM Quality Care stock overvalued right now?
Based on GuruFocus' analysis, Aster DM Quality Care (NSE:ASTERDM) is currently considered Modestly Overvalued. The stock's GF Value™ is ₹724.56, compared to a current price of ₹822.15 — trading 13.5% above its estimated fair value. The current Growth Rank is 7, which is 17% above median its 10-year median of 6.00. Aster DM Quality Care's overall GF Score™ is 72/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Growth Rank calculated?
Growth Rank is calculated from a company's financial statements. For Aster DM Quality Care (NSE:ASTERDM), the current Growth Rank is 7 as of Aug. 03, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Aster DM Quality Care (NSE:ASTERDM) Overvalued in 2026?

Based on GuruFocus' analysis, Aster DM Quality Care stock appears to be overvalued. The current stock price of ₹822.15 is trading 13.5% above its estimated GF Value™ of ₹724.56. GuruFocus considers Aster DM Quality Care to be Modestly Overvalued.

Key valuation signals for NSE:ASTERDM:

  • Growth Rank: 7 (17% above median its 10-year median of 6.00)
  • GF Value™: ₹724.56 vs. price of ₹822.15 (13.5% above fair value)
  • GF Score™: 72/100 with 7 warning signs

No single metric tells the full story. See the NSE:ASTERDM stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Aster DM Quality Care Business Description

Other Exchanges 540975:India
Address 27 and 27/1, Mission Road, Awfis, 2nd Floor, Renaissance Centra, Sampangirama Nagar, Bengaluru, KA, IND, 560027
Aster DM Healthcare Ltd is an India-based integrated healthcare provider. The group operates a comprehensive healthcare network comprising approximately 19 hospitals, 10 clinics, over 200 pharmacies, and more than 255 diagnostic laboratories across states. Its business segments include Hospitals, Clinics, Retail Pharmacies, and Others, with the majority of revenue derived from the Hospitals segment. Aster has been delivering high-quality care from primary to quaternary through dedicated personnel across clinical and non-clinical roles. Aster has a presence in metropolitan as well as Tier II and Tier III cities, and is committed to providing advanced and accessible healthcare in line with global standards, guided by a patient-first approach.
72GF Score

Get the complete analysis for NSE:ASTERDM

Growth Rank is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹822.15
Price
₹724.56
GF Value